• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,409.98 254.36
( 0.33%)
Global Indices
Nasdaq
51,515.27 -505.40
(-0.97%)
Dow Jones
7,441.22 -91.13
(-1.21%)
Hang Seng
71,050.31 1,148.06
(1.64%)
Nikkei 225
10,394.87 -113.74
(-1.08%)
Forex
USD-INR
94.55 -0.09
(-0.09%)
EUR-INR
109.66 -0.13
(-0.12%)
GBP-INR
126.84 -0.25
(-0.20%)
JPY-INR
0.59 0.00
(-0.20%)

EQUITY - MARKET SCREENER

Genpharmasec Ltd
Industry :  Trading
BSE Code
ISIN Demat
Book Value()
531592
INE861N01036
1.291122
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
11.3
62.57
EPS(TTM)
Face Value()
Div & Yield %
0.1
1
0
 

ITI reports consolidated net profit of Rs 375.14 crore in the March 2026 quarter
May 30,2026
Net profit of ITI reported to Rs 375.14 crore in the quarter ended March 2026 as against net loss of Rs 4.38 crore during the previous quarter ended March 2025. Sales declined 39.98% to Rs 627.65 crore in the quarter ended March 2026 as against Rs 1045.70 crore during the previous quarter ended March 2025.

For the full year,net profit reported to Rs 292.83 crore in the year ended March 2026 as against net loss of Rs 214.89 crore during the previous year ended March 2025. Sales declined 39.62% to Rs 2183.72 crore in the year ended March 2026 as against Rs 3616.42 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales627.651045.70 -40 2183.723616.42 -40
OPM %-17.74-2.69 -2.00-1.66 -
PBDT-178.94-37.87 -373 -99.87-180.73 45
PBT-83.90-66.79 -26 -156.32-249.93 37
NP375.14-4.38 LP 292.83-214.89 LP